نتایج جستجو برای: sle disease activity

تعداد نتایج: 2482885  

Journal: :Arthritis and rheumatism 2004
Michelle A Petri Philip J Mease Joan T Merrill Robert G Lahita Mark J Iannini David E Yocum Ellen M Ginzler Robert S Katz Oscar S Gluck Mark C Genovese Ronald Van Vollenhoven Kenneth C Kalunian Susan Manzi Maria W Greenwald Jill P Buyon Nancy J Olsen Michael H Schiff Arthur F Kavanaugh Jacques R Caldwell Rosalind Ramsey-Goldman E William St Clair Allan L Goldman Rita M Egan Richard P Polisson Kevin G Moder Naomi F Rothfield Robert T Spencer Kathryn Hobbs Barri J Fessler Leonard H Calabrese Larry W Moreland Stanley B Cohen Betty J Quarles Vibeke Strand Marc Gurwith Kenneth E Schwartz

OBJECTIVE To determine whether prasterone administration results in improvement or stabilization of systemic lupus erythematosus (SLE) disease activity and its symptoms. METHODS Women with active SLE were treated with prasterone 200 mg/day plus standard SLE treatments or with placebo plus standard SLE treatments for up to 12 months in this randomized, double-blind investigation conducted at 2...

2011
Simona Coman Mirela Parvu Lia Georgescu

Background: Systemic lupus erythematosus (SLE) patients have a significantly increased risk of coronary heart disease (CHD) that is not fully explained by classic risk factors. Endothelial dysfunction is an early stage in the process of atherogenesis. Our aim was to determine whether endothelial dysfunction occurs in SLE and whether it is associated with the occurrence of classic Framingham ris...

Journal: :Frontiers in bioscience : a journal and virtual library 2004
Hayden Zaccagni Justin Fried John Cornell Patricia Padilla Robin L Brey

Nervous system dysfunction may occur in as many as 80% of patients with Systemic Lupus Erythematous (SLE) at some point in their disease course. Upregulation of adhesion molecules has been linked to acute SLE-related disease activity and chronic damage. We evaluated the relationship between soluble adhesion molecule levels and neuropsychiatric lupus (NPSLE) manifestations using the American Col...

Journal: :Lupus 2014
L López-López M Nieves-Plaza M del R Castro Y M Font C A Torres-Ramos L M Vilá S Ayala-Peña

OBJECTIVE To determine the extent of mitochondrial DNA (mtDNA) damage in systemic lupus erythematosus (SLE) patients compared to healthy subjects and to determine the factors associated with mtDNA damage among SLE patients. METHODS A cross-sectional study was performed in 86 SLE patients (per American College of Rheumatology classification criteria) and 86 healthy individuals matched for age ...

2017
Marina Eloi Daniela Vargas Horvath João Carlos Ortega Mônica Simon Prado Luis Eduardo Coelho Andrade Vera Lúcia Szejnfeld Charlles Heldan de Moura Castro

We aim to evaluate the prevalence of vitamin D deficiency in patients with systemic lupus erythematosus (SLE) and investigate the association between total, free and bioavailable vitamin D serum concentrations and disease activity. Patients with SLE (ACR 1997) consecutively seen at UNIFESP's outpatient's clinics had disease activity measured after clinical and laboratory evaluation using SLEDAI...

2016
Anders A. Bengtsson Johan Trygg Dirk M. Wuttge Gunnar Sturfelt Elke Theander Magdalena Donten Thomas Moritz Carl-Johan Sennbro Frida Torell Christian Lood Izabella Surowiec Stefan Rännar Torbjörn Lundstedt

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease which can affect most organ systems including skin, joints and the kidney. Clinically, SLE is a heterogeneous disease and shares features of several other rheumatic diseases, in particular primary Sjögrens syndrome (pSS) and systemic sclerosis (SSc), why it is difficult to diagnose The pathogenesis of SLE is not com...

2011
Jun Wu Carl Ekman Andreas Jönsen Gunnar Sturfelt Anders A Bengtsson Anders Gottsäter Bengt Lindblad Elisabet Lindqvist Tore Saxne Björn Dahlbäck

INTRODUCTION Mer and Tyro3 are receptor tyrosine kinases important for the phagocytosis of apoptotic cells. Together with Axl, they constitute the TAM receptor family. These receptors can be shed from the cell membrane and their soluble extracellular regions can be found in plasma. The objective of this study was to elucidate whether the plasma levels of soluble Mer (sMer) and Tyro3 (sTyro3) we...

Journal: :Arthritis and rheumatism 2006
Nathalie Costedoat-Chalumeau Zahir Amoura Jean-Sébastien Hulot Hala Abou Hammoud Guy Aymard Patrice Cacoub Camille Francès Bertrand Wechsler Du Le Thi Huong Pascale Ghillani Lucile Musset Philippe Lechat Jean-Charles Piette

OBJECTIVE To study the possible relationship between whole-blood hydroxychloroquine (HCQ) concentrations and clinical efficacy of HCQ in patients with systemic lupus erythematosus (SLE). METHODS Whole-blood HCQ concentrations were measured, under blinded conditions, in 143 unselected patients with SLE who had been receiving HCQ 400 mg daily for at least 6 months. The relationship of these con...

Journal: :Mediators of Inflammation 1999
E Waszczykowska E Robak A Wozniacka J Narbutt J D Torzecka A Sysa-Jedrzejowska

We estimated the serum levels of IL-6, TNF-alpha and IL-10, and generation of superoxide radicals, as well as their mutual dependence, in 63 SLE patients at various stages of disease activity. Our results indicate a statistically significant increase of the serum levels studied, and an increase of superoxide anion generation by granulocytes, in correlation with SLE activity. These results indic...

Journal: :Seminars in arthritis and rheumatism 2004
Yaniv Sherer Alexander Gorstein Marvin J Fritzler Yehuda Shoenfeld

OBJECTIVE Description of the various autoantibodies that can be detected in patients with systemic lupus erythematosus (SLE). METHODS A literature review, using the terms "autoantibody" and "systemic lupus erythematosus", was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity, or other clinical associations. RESULTS One hundre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید